Correction to: Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review (Clinical and Translational Imaging, (2024), 12, 2, (187-195), 10.1007/s40336-024-00618-3)

Sambavy Nadaraja*, Jonas Helsing, Mohammad Naghavi-Behzad, Lotte H. Land, Christina H. Ruhlmann, Oke Gerke, Malene G. Hildebrandt

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Abstract

In this article the author name Mohammad Naghavi-Behzad was incorrectly written as Mohammad Naghavi-Bezhad. The original article has been corrected.

Original languageEnglish
JournalClinical and Translational Imaging
Volume12
Issue number3
Pages (from-to)373
Number of pages1
ISSN2281-5872
DOIs
Publication statusPublished - Jun 2024

Fingerprint

Dive into the research topics of 'Correction to: Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review (Clinical and Translational Imaging, (2024), 12, 2, (187-195), 10.1007/s40336-024-00618-3)'. Together they form a unique fingerprint.

Cite this